CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

T-follicular helper (TFH) lymphoma is a blood cancer subgroup that continues to demonstrate a generally poor prognosis, with no standard treatment established to date. Although specific genetic ...

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

Immunotherapy is gaining traction as a prominent approach to cancer treatment. These therapies encompass the use of Chimeric ...

Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

Adding IL-12 to mRNA vaccines can lead to longer lasting protective effect and a potential approach for reducing the risk of ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

Neowise Biotechnology ('Neowise'), a pioneering company focused on the development of TCR-T cell therapies for solid tumors, announced today that it has entered into a non-exclusive licensing ...

Scientists are always searching for new weapons to add to their arsenal in the pursuit of creating vaccinations that would ...

TIM3-blockade synergizes with IL2 in alleviating intra-tumoral CD8 + T cell exhaustion Blockade of alternative T cell checkpoint molecules, such as Tim3, is a promising alternative to inhibition ...